Close
Nordic 9Nordic 9

Marc Gare (investor - Angel Investor)

United States
See something wrong or missing? Let us know

Marc Gare is a co-founder of Advanced Grow Labs in the US

Average round investment:N/A USD
Average number per year:0.0
Distribution: 2021 (1)
Portfolio companies: Portugal AceCann
Mostly invests in: Portugal Portugal (1) Agriculture (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Marc Gare

Name Criteria
United States Chris Mayle
80%
  • Range for average deal size: n/a USD
  • Similar verticals: Agriculture, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Portugal
  • Active last 12 months: Yes
United States Frank Cid
80%
  • Range for average deal size: n/a USD
  • Similar verticals: Agriculture, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Portugal
  • Active last 12 months: Yes
Portugal Lince Capital
80%
  • Range for average deal size: n/a USD
  • Similar verticals: Agriculture, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Portugal
  • Active last 12 months: Yes
Canada Sebastian De La Rosa
80%
  • Range for average deal size: n/a USD
  • Similar verticals: Agriculture, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Portugal
  • Active last 12 months: Yes
United States Casa Verde Capital
80%
  • Range for average deal size: n/a USD
  • Similar verticals: Agriculture, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Portugal
  • Active last 12 months: Yes
Norway FSN Capital
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Agriculture, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Finland Nostetta Ventures
66%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Sweden Mertiva
63%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Sweden Unionen
63%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
Norway LongShip AS
63%
  • Range for average deal size: n/a USD
  • Similar verticals: Agriculture, Health services
  • Similar business models: B2B
Top